When reports emerged late last month that Microsoft is now the subject of an antitrust investigation by Chinese regulators, little information was available about why, exactly, the company was targeted.
But with new information trickling in about the probe, some new questions arise.
According to reports, Chinese officials raided Microsoft offices in four major cities on July 28; the next day, officials launched an antitrust investigation into the company, Windows and Office.
The nation’s State Administration for Industry and Commerce first began eyeing the company in June following a complaint that Windows and Office products caused compatibility and document verification issues. Reports say there were also complaints of bundling practices Microsoft uses with the products.
But reports say it is unclear exactly how these complaints related to matters of competition in the industry. More likely, some experts say, the probe is more closely related to political tensions between China and the US, and China’s distrust of Western spying through technological companies.
Full content: Nasdaq
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas